
Elevance Health (NYSE:ELV) Receives New Coverage from Analysts at StockNews.com
A number of other equities analysts have also recently issued reports on ELV. Deutsche Bank Aktiengesellschaft increased their target price on Elevance Health from $571.00 to $575.00 in a report on Thursday, April 20th. Cantor Fitzgerald began coverage on Elevance…












